相关实验视频

Updated: Sep 17, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

早期的动脉内气球支持与心力衰竭有关的心脏性休克:一项随机临床试验

Nuccia Morici¹, Alice Sacco², Simone Frea³

¹IRCCS Fondazione Don Gnocchi, ONLUS, Santa Maria Nascente, Milan, Italy.

Journal of the American College of Cardiology

|March 31, 2025

概括

早期动脉内气球 (IABP) 的使用没有改善心力衰竭-心脏性休克 (HF-CS) 患者的存活率或心脏替代疗法 (HRT) 桥梁. 阿尔茨霍克-2试验因徒劳而提前停止,在标准护理上没有显著的益处.

科学领域:

心脏病学心脏病学
关键护理医学关键护理医学
机械循环支持机械循环支持

背景情况:

动脉内气球 (IABP) 在改善心力衰竭-心脏性休克 (HF-CS) 患者的治疗结果方面的疗效尚未得到充分证实.
将心脏替代疗法 (HRT) 连接到心脏替代疗法 (HRT) 的成功是管理先进的HF-CS的关键目标.

研究的目的:

为了确定早期IABP的实施,以及标准护理,是否提高60天的生存率或成功的HRT桥梁在HF-CS患者.
在一个前性的多中心试验中,比较早期IABP与标准护理的结果.

主要方法:

未来的多中心Altshock-2试验随机选择了101名患有HF-CS (B,C或D阶段) 的患者,接受早期IABP加标准护理或单独标准护理.
主要终点是60天的生存或成功的HRT桥梁.
二级终点包括整体存活率,内的支持需求和器官衰竭得分.

主要成果:

由于临时分析的徒劳,试验被提前停止.
主要终点在IABP组达到81%,对照组达到75% (HR:0.72;P=0.45),表明没有显著差异.
两组之间的并发症率和HRT使用率相似.

结论:

常规早期IABP使用在患有HF-CS的患者中没有显著改善60天生存率或HRT桥梁.
这些发现表明,早期的IABP对于这个患者群体来说并不优于标准护理.

关键词:

心脏衰竭-心脏源性休克心脏替代疗法心脏替代疗法动脉内气球 - 动脉内气球

更多相关视频

The Intra-Aortic Balloon Pump

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

相关概念视频

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.